Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS, MISCELLANEOUS

Patient Choice Announces New Partnerships with Medical Licensed Producers - Dykstra Greenhouses, Lupos Biotechnology, and Parkland Flower.


Toronto, March 03, 2021 (GLOBE NEWSWIRE) -- Patient Choice is a one-stop-shop that gives registered medical cannabis patients across Canada flexible and convenient freedom to purchase their medicine from a range of different providers. Their goal is to provide convenient access to a broad variety of high-quality and fairly priced medical cannabis. They have partnered with robust and trusted producers of high-quality medical cannabis.

"Partnering with trusted licensed producers increases our continuing effort to offer our patients superior medical cannabis products," says Andrew Richard, Co-Founder & Chief Operations Officer of Patient Choice.

" Partnering with Patient Choice allows us to focus on growing superior products instead of worrying about administration - it is a dream partnership where everyone benefits," says Larry Dykstra, Dykstra Greenhouses.

Patient Choice has partnered with Dykstra Greenhouses, Lupos Biotechnology, and Parkland Flower, federally Licensed Producers and Processors, to  bring top-quality medical cannabis products to Patient Choice consumers.  

"Our goal is to have easy access of our clones and seeds to patients, and with Patient Choice, we can accomplish this goal," adds Kieley Beaudry, Parkland Flower.

Patient Choice operates on a non-possession model, which means they don't hold inventory. Products are delivered fresh and direct from producers to patients. That approach allows patients to have access to a wide range of quality products, not just products from one licensed producer or those that sell a lot of volume. 

"This is a great opportunity for us to join a trusted medical platform to offer Proofly topical products to Canadian patients through Patient Choice," adds John King, CEO, Lupos Biotech.

Patient Choice continues to diversify their offering with a robust and trusted selection of producers of high-quality medical cannabis. With a trustworthy, licensed, and compliant medical platform, producers can highlight & sell their products to a large and ever-increasing group of Canadian patients; patients who use the Patient Choice platform because they trust to be connected to high-quality medical cannabis.


For more information visit Patient Choice website. 



ABOUT Patient Choice:

Patient Choice is here to redefine the way patients receive and access medical cannabis.Our goal is to provide you with convenient access to a broad variety of high-quality and fairly priced medical cannabis products to support your health and wellness goals. Patient Choice is brought to you by Empress Agri Sales Inc, a Health Canada Medical Sales License holder under the Cannabis Act. We're passionate about leading the charge to create a fair and equitable new ecosystem that protects patients and supports craft producers.



MEDIA INQUIRIES:

Amanda Lockington, Account Executive at [email protected] or 1-877-681-5541.




Contact Lupos (Canada) Biotechnology Inc. 1 (855) 554-1217 [email protected]

Contact Dykstra Greenhouses 905-932-2812 [email protected]

Contact Parkland Flower 780.266.9996



These press releases may also interest you

at 23:15
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: